http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1240905-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bef96a52ca9eaf6230a857ba74af9a1
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-099
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-05
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-116
filingDate 1997-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1c8e0cb9eee116f98bfe55aef3fb68d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47f7a64a0619f10950ed9a849fd95a1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e021589c3b7958b2f1b763b09cf6cdbc
publicationDate 2002-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1240905-A1
titleOfInvention Acellular pertussis vaccine with diphtheriae- and tetanus-toxoids
abstract The invention provides a diphtheria, tetanus and pertussis vaccine comprising anlow dose of each of diphtheria toxoid (D), tetanus toxoid (T), pertussis toxin (PT),nfilamentous haemagglutinin (FHA) and pertactin (69K). The vaccine maintainsnan ability to prevent pertussis while showing exceptionally low reactogenicity.nCombination vaccines comprising additional antigens are also provided.
priorityDate 1996-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0304578-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0299108-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9324148-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9114703-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0198474-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0278940-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0414374-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0226846-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129001639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3053
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406018
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406017
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17848643
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31236
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129054986

Total number of triples: 46.